DE69111029T2 - Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung. - Google Patents

Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.

Info

Publication number
DE69111029T2
DE69111029T2 DE69111029T DE69111029T DE69111029T2 DE 69111029 T2 DE69111029 T2 DE 69111029T2 DE 69111029 T DE69111029 T DE 69111029T DE 69111029 T DE69111029 T DE 69111029T DE 69111029 T2 DE69111029 T2 DE 69111029T2
Authority
DE
Germany
Prior art keywords
substituted
group
amino
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69111029T
Other languages
German (de)
English (en)
Other versions
DE69111029D1 (de
Inventor
Giichi Toyono-Gun Osaka 563-01 Goto
Yuji Itami Hyogo 664 Ishihara
Masaomi Takarazuka Hyogo 665 Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69111029D1 publication Critical patent/DE69111029D1/de
Application granted granted Critical
Publication of DE69111029T2 publication Critical patent/DE69111029T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Containers Having Bodies Formed In One Piece (AREA)
DE69111029T 1990-11-22 1991-11-21 Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung. Expired - Fee Related DE69111029T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP31989790 1990-11-22
JP7028691 1991-01-14
JP20935891 1991-08-21
JP24376891 1991-09-24

Publications (2)

Publication Number Publication Date
DE69111029D1 DE69111029D1 (de) 1995-08-10
DE69111029T2 true DE69111029T2 (de) 1995-12-14

Family

ID=27465225

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69111029T Expired - Fee Related DE69111029T2 (de) 1990-11-22 1991-11-21 Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.

Country Status (19)

Country Link
US (1) US5273974A (enExample)
EP (1) EP0487071B1 (enExample)
JP (1) JP2650537B2 (enExample)
KR (1) KR100211437B1 (enExample)
CN (1) CN1036458C (enExample)
AT (1) ATE124695T1 (enExample)
AU (1) AU643337B2 (enExample)
CA (1) CA2055947C (enExample)
DE (1) DE69111029T2 (enExample)
DK (1) DK0487071T3 (enExample)
ES (1) ES2074205T3 (enExample)
FI (2) FI982436A7 (enExample)
GR (1) GR3017366T3 (enExample)
HU (2) HU214573B (enExample)
IE (1) IE68346B1 (enExample)
NO (1) NO179868C (enExample)
NZ (1) NZ240676A (enExample)
RU (1) RU2095361C1 (enExample)
TW (1) TW197435B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965574A (en) * 1996-08-13 1999-10-12 Chen; Yuhpyng Liang Heteroaryl amines as novel acetylcholinesterase inhibitors
TW263504B (enExample) * 1991-10-03 1995-11-21 Pfizer
US5462934A (en) * 1992-03-09 1995-10-31 Takeda Chemical Industries Condensed heterocyclic ketone derivatives and their use
TW218875B (enExample) * 1992-03-09 1994-01-11 Takeda Pharm Industry Co Ltd
DE69329084T2 (de) 1992-04-24 2000-12-21 Takeda Chemical Industries, Ltd. Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
TW248556B (enExample) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
US5674891A (en) * 1994-07-27 1997-10-07 The Procter & Gamble Company Dihydrobenzothiophene compounds useful as anti-inflammatory agents
CA2196054C (en) * 1994-07-27 2001-04-17 Michael Wiard Scherz Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
ES2241064T3 (es) 1996-12-18 2005-10-16 Teva Pharmaceutical Industries, Ltd. Derivados de aminoindano.
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
WO1998031356A1 (en) * 1997-01-17 1998-07-23 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease
CA2282390A1 (en) * 1997-04-17 1998-10-22 Yukio Fujisawa Thermogenic composition and benzazepine thermogenics
RU2222815C2 (ru) * 1997-10-09 2004-01-27 Дексел Фарма Текнолоджис Элтиди. Лекарственная форма для доставки и непосредственного локализованного освобождения желаемого агента в желудочно-кишечном тракте животного и способ доставки желаемого агента в желудочно-кишечный тракт животного (варианты)
WO1999032478A1 (en) * 1997-12-19 1999-07-01 G.D. Searle & Co. Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
AU3534799A (en) * 1998-04-23 1999-11-08 Takeda Chemical Industries Ltd. Pharmaceutical composition for neurotrophic action
EP1118322A4 (en) 1998-09-30 2004-10-20 Takeda Chemical Industries Ltd MEDICINES THAT IMPROVE BLADDER DRAINING POWER
KR100694682B1 (ko) 1999-03-03 2007-03-13 에자이 알앤드디 매니지먼트 가부시키가이샤 4-치환 피페리딘 유도체 불화물
CA2414976A1 (en) * 2000-07-04 2002-01-10 Takeda Chemical Industries, Ltd. Gpr14 antagonistic agent
WO2002014513A1 (fr) * 2000-08-10 2002-02-21 Takeda Chemical Industries, Ltd. Utilisation de polypeptide
CN1317276C (zh) * 2000-09-29 2007-05-23 中国科学院上海药物研究所 一类吲哚基哌啶类化合物及其制备方法和用途
US7132547B2 (en) 2001-12-28 2006-11-07 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
ATE378330T1 (de) * 2002-04-16 2007-11-15 Schering Corp Trizyklische thrombin rezeptor antagonisten
KR100935615B1 (ko) 2002-06-14 2010-01-07 토야마 케미칼 컴퍼니 리미티드 뇌기능을 개선하는 의약조성물 및 뇌기능을 개선하기 위한방법
ES2333008T3 (es) 2002-12-20 2010-02-16 Glaxo Group Limited Derivados de benzo(d)azepina para el tratamiento de trastornos neurologicos.
JPWO2006004201A1 (ja) * 2004-07-01 2008-04-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 神経再生促進剤
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
CN103142570A (zh) * 2005-12-09 2013-06-12 耶路撒冷希伯来大学伊森姆研究发展公司 低剂量Ladostigil 用于神经保护的用途
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
CN102099339A (zh) * 2008-07-18 2011-06-15 武田药品工业株式会社 苯并氮杂衍生物及其作为组胺h3拮抗剂的用途
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
CN109880635B (zh) * 2019-03-19 2021-02-02 石家庄晶奥量新材料有限公司 含有二苯并呋喃并含氧杂环类液晶化合物和组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4208417A (en) * 1978-06-29 1980-06-17 Pharmindustrie Indole derivatives and their use as anxiolytics
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
CA2023492A1 (en) * 1989-08-31 1991-03-01 Barry Clifford Lange Herbicidal glutarimides
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines

Also Published As

Publication number Publication date
EP0487071B1 (en) 1995-07-05
NZ240676A (en) 1993-05-26
KR100211437B1 (ko) 1999-08-02
FI915488L (fi) 1992-05-23
CN1062143A (zh) 1992-06-24
CA2055947C (en) 2002-03-12
ATE124695T1 (de) 1995-07-15
FI982436A0 (fi) 1998-11-10
AU643337B2 (en) 1993-11-11
CN1036458C (zh) 1997-11-19
TW197435B (enExample) 1993-01-01
HUT59676A (en) 1992-06-29
ES2074205T3 (es) 1995-09-01
IE914053A1 (en) 1992-06-03
HU214573B (hu) 2000-04-28
US5273974A (en) 1993-12-28
RU2095361C1 (ru) 1997-11-10
DE69111029D1 (de) 1995-08-10
AU8804591A (en) 1992-05-28
NO914558D0 (no) 1991-11-21
JPH05140149A (ja) 1993-06-08
KR920009823A (ko) 1992-06-25
JP2650537B2 (ja) 1997-09-03
FI915488A0 (fi) 1991-11-21
FI102965B1 (fi) 1999-03-31
HU913643D0 (en) 1992-02-28
IE68346B1 (en) 1996-06-12
HU211130A9 (en) 1995-10-30
FI102965B (fi) 1999-03-31
NO179868B (no) 1996-09-23
FI982436L (fi) 1998-11-10
NO914558L (no) 1992-05-25
DK0487071T3 (da) 1995-10-30
GR3017366T3 (en) 1995-12-31
EP0487071A1 (en) 1992-05-27
CA2055947A1 (en) 1992-05-23
NO179868C (no) 1997-01-02
FI982436A7 (fi) 1998-11-10

Similar Documents

Publication Publication Date Title
DE69111029T2 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
DE69315920T2 (de) Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
DE69010232T2 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE69612003T2 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
DE69225500T2 (de) Chinazolinone als mittel gegen angina
DE69431069T2 (de) Cyclische amidderivate als neurokinin a antagonisten
DE69922186T2 (de) 1-(1-subst.-4-piperidinyl)methyl]-4-piperidin-derivate, verafhren zu deren herstellung, pharmazeutische mixturen und intermediate zu deren herstellung
DE60120138T2 (de) Amid-verbindungen und deren verwendung
DE69806141T2 (de) Indazoleamid-verbindungen als serotoninergene mittel
DE69111815T2 (de) Piperazinylderivate mit Affinität zu 5-HT Rezeptoren.
DE69433148T2 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
DE69427023T2 (de) Tricyclische benzazepin-und benzothiazepin derivate
DE69311165T2 (de) Kondensierte heterocyclische Ketonderivate, ihre Herstellung und ihre Verwendung
DE69733427T2 (de) Tetrahydrobezindol derivate
DE68922478T2 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE3878371T2 (de) Psychotropische bizyklische imide.
DE69427517T2 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
EP0221376B1 (de) N-substituierte Diphenylpiperidine
DE69829317T2 (de) Tetrahydrobenzindol-derivate
DE69828284T2 (de) Naphthyridinderivate oder salze davon
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
DE60313898T2 (de) Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
DE69029954T2 (de) Pyridinderivate
DE68916979T2 (de) Alkylen-diamine.
DE69623610T2 (de) Neue heterozyklische chemie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee